EMBOCEPT Trademark

Trademark Overview

On Tuesday, October 18, 2016, a trademark application was filed for EMBOCEPT with the United States Patent and Trademark Office. The USPTO has given the EMBOCEPT trademark a serial number of 79200744. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Sunday, February 4, 2024. This trademark is owned by PharmaCept GmbH. The EMBOCEPT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, embolisates
embocept

General Information

Serial Number79200744
Word MarkEMBOCEPT
Filing DateTuesday, October 18, 2016
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSunday, February 4, 2024
Registration Number5215890
Registration DateTuesday, June 6, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, embolisates

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 6, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePharmaCept GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNOT AVAILABLE
Party NamePharmaCept GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDE
Party NamePharmaCept GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDE

Trademark Events

Event DateEvent Description
Sunday, February 4, 2024NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Sunday, February 4, 2024REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Sunday, February 4, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 31, 2023TEAS SECTION 71 & 15 RECEIVED
Thursday, April 28, 2022CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sunday, March 20, 2022CORRECTION TRANSACTION RECEIVED FROM IB
Friday, March 11, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 4, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 12, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 20, 2020NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 28, 2017NOTIFICATION PROCESSED BY IB
Friday, July 7, 2017FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 7, 2017FINAL DISPOSITION PROCESSED
Thursday, July 6, 2017GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, June 6, 2017REGISTERED-PRINCIPAL REGISTER
Saturday, March 25, 2017NOTIFICATION PROCESSED BY IB
Tuesday, March 21, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 8, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 8, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 1, 2017NOTICE OF PUBLICATION
Friday, February 10, 2017APPLICATION FILING RECEIPT MAILED
Wednesday, February 8, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 6, 2017ASSIGNED TO EXAMINER
Monday, February 6, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 2, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

embocept embolisates namely preparations pharmaceutical